tradingkey.logo

Kamada Ltd

KMDA
8.210USD
+0.190+2.37%
終値 02/06, 16:00ET15分遅れの株価
473.56M時価総額
23.35直近12ヶ月PER

Kamada Ltd

8.210
+0.190+2.37%

詳細情報 Kamada Ltd 企業名

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Kamada Ltdの企業情報

企業コードKMDA
会社名Kamada Ltd
上場日Aug 01, 2005
最高経営責任者「CEO」London (Amir)
従業員数374
証券種類Ordinary Share
決算期末Aug 01
本社所在地2 Holtzman St., Science Park
都市REHOVOT
証券取引所NASDAQ OMX - NASDAQ BASIC
Israel
郵便番号7670402
電話番号97289406472
ウェブサイトhttps://www.kamada.com/
企業コードKMDA
上場日Aug 01, 2005
最高経営責任者「CEO」London (Amir)

Kamada Ltdの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
+1875.00%
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Dr. Ruth Wolfson
Dr. Ruth Wolfson
Senior Vice President - Scientific Affairs
Senior Vice President - Scientific Affairs
--
--
Ms. Pnina Strauss
Ms. Pnina Strauss
Vice President - Inhalation programs & IP
Vice President - Inhalation programs & IP
--
--
Mr. Tuvia Shoham
Mr. Tuvia Shoham
Independent Director
Independent Director
--
--
Dr. Abraham (Avri) Havron, Ph.D.
Dr. Abraham (Avri) Havron, Ph.D.
Independent Director
Independent Director
--
--
DR. Naveh Tov
DR. Naveh Tov
Vice President-Clinical Development and Medical Director for Pulmonary Diseases
Vice President-Clinical Development and Medical Director for Pulmonary Diseases
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Leon Yehuda Recanati
Mr. Leon Yehuda Recanati
Director
Director
631.14K
--
Mr. David Tsur
Mr. David Tsur
Deputy Chairman of the Board
Deputy Chairman of the Board
607.93K
--
Mr. Amir London
Mr. Amir London
Chief Executive Officer
Chief Executive Officer
61.88K
+1875.00%
Ms. Orit Pinchuk
Ms. Orit Pinchuk
Vice President - Regulatory Affairs and Quality R&D
Vice President - Regulatory Affairs and Quality R&D
12.13K
--
Ms. Yael Brenner
Ms. Yael Brenner
Vice President - Quality
Vice President - Quality
6.27K
--
Dr. Ruth Wolfson
Dr. Ruth Wolfson
Senior Vice President - Scientific Affairs
Senior Vice President - Scientific Affairs
--
--

収益内訳

通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
U.S.A
23.74M
50.49%
Israel
9.20M
19.56%
Latin America
6.44M
13.71%
Europe
3.86M
8.21%
Canada
2.39M
5.08%
他の
1.39M
2.96%
事業別
地域別
会社から関連データがまだ開示されていません。

株主

更新時刻: Sat, Feb 7
更新時刻: Sat, Feb 7
株主統計
種類
株主統計
株主統計
比率
First Israel Mezzanine Investors Ltd.
38.29%
Gov Financial Holdings, Ltd.
4.86%
Phoenix Investment and Finances Ltd
2.87%
Renaissance Technologies LLC
1.51%
Recanati (Leon Yehuda)
1.09%
他の
51.38%
株主統計
株主統計
比率
First Israel Mezzanine Investors Ltd.
38.29%
Gov Financial Holdings, Ltd.
4.86%
Phoenix Investment and Finances Ltd
2.87%
Renaissance Technologies LLC
1.51%
Recanati (Leon Yehuda)
1.09%
他の
51.38%
種類
株主統計
比率
Private Equity
38.29%
Corporation
4.86%
Investment Advisor
4.24%
Investment Advisor/Hedge Fund
3.03%
Hedge Fund
2.45%
Individual Investor
2.34%
Research Firm
1.61%
Pension Fund
0.14%
Bank and Trust
0.02%
他の
43.02%

機関投資家保有株

更新時刻: Thu, Jan 1
更新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
90
28.82M
49.96%
-1.10M
2025Q3
77
26.81M
46.48%
-3.11M
2025Q2
80
32.16M
55.76%
-1.16M
2025Q1
80
31.87M
55.42%
-1.29M
2024Q4
72
32.96M
57.32%
-768.38K
2024Q3
87
33.30M
57.92%
-790.28K
2024Q2
91
33.17M
57.70%
-784.97K
2024Q1
93
32.46M
56.47%
-1.61M
2023Q4
102
32.56M
56.63%
-1.63M
2023Q3
106
34.53M
63.12%
+10.56M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
First Israel Mezzanine Investors Ltd.
22.08M
38.29%
--
--
Dec 31, 2024
Gov Financial Holdings, Ltd.
2.80M
4.86%
-55.95K
-1.96%
Dec 31, 2024
Phoenix Investment and Finances Ltd
1.65M
2.87%
--
--
Sep 30, 2025
Renaissance Technologies LLC
871.98K
1.51%
+39.97K
+4.80%
Sep 30, 2025
Recanati (Leon Yehuda)
631.14K
1.09%
--
--
Dec 31, 2024
Tsur (David)
607.93K
1.05%
--
--
Dec 31, 2024
Wells Fargo Advisors
606.30K
1.05%
-4.17K
-0.68%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
449.03K
0.78%
+10.81K
+2.47%
Dec 31, 2025
Essex Investment Management Company, LLC
396.43K
0.69%
+72.60K
+22.42%
Sep 30, 2025
More Investment House Ltd.
269.67K
0.47%
-60.04K
-18.21%
Sep 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Avantis International Small Cap Equity ETF
0.01%
DFA Dimensional International Small Cap ETF
0.01%
Dimensional International Core Equity Market ETF
0%
ARK Israel Innovative Technology ETF
0%
Avantis International Equity ETF
0%
Vanguard Total World Stock Index Fund
0%
Vanguard ESG International Stock ETF
0%
Schwab International Small-Cap Equity ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
DFA Dimensional International Small Cap Value ETF
0%
Avantis International Small Cap Equity ETF
比率0.01%
DFA Dimensional International Small Cap ETF
比率0.01%
Dimensional International Core Equity Market ETF
比率0%
ARK Israel Innovative Technology ETF
比率0%
Avantis International Equity ETF
比率0%
Vanguard Total World Stock Index Fund
比率0%
Vanguard ESG International Stock ETF
比率0%
Schwab International Small-Cap Equity ETF
比率0%
DFA Dimensional International Core Equity 2 ETF
比率0%
DFA Dimensional International Small Cap Value ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
KeyAI